Brazil’s health regulator approved the Pfizer-BioNTech Covid-19 vaccine Thursday for use in children aged five to 11, joining a growing list of countries green-lighting vaccination for kids.
However, it is not clear when the hard-hit South American country will begin vaccinating children, if at all.
The matter now passes to the health ministry, which will first have to decide whether to add Covid-19 vaccines for five- to 11-year-olds to the national immunization program and acquire child-size doses — one-third the adult dose.